Press release
Poultry Vaccines Market Expected to Exceed USD 8.1 Billion by 2031 as Biosecurity, Sustainability, and Recombinant Technologies Influence Global Immunization Programs
Request Sample @ https://clearviewmarketinsights.com/report-details/global-poultry-vaccines-market/
2024 Industry Milestones:
Hatchery Vaccine Automation Expands in Asia and LATAM
• Ceva is installing over 150 automated in ovo and spray stations in India, Brazil, and Vietnam.
mRNA Vaccines Enter Pilot Trials
• U.S. and EU veterinary companies initiate trials for rapid-response avian influenza mRNA vaccine platforms
Multivalent Combo Vaccines Reduce Labor Costs
• Zoetis introduces Poulvac® Combo ND + IBD + IB in single dose format
Executive Insights:
"Vaccination is no longer an option-it's a prerequisite for scale, trust, and resilience in poultry systems," said Dr. Mikkel Johansson, Global Poultry Vaccine Lead, Clearview Market Insights.
"Recombinant vaccines, delivered in ovo or via spray, are now frontline tools in the fight against zoonoses and productivity loss," added Marta Alvarez, Technical Director, MSD Animal Health.
Roadmap to 2031:
• 2025: Recombinant vaccines comprise 25% of the total poultry vaccine market.
• 2026: Blockchain-based vaccine records connected to traceability platforms in the EU and ASEAN.
• 2028: AI-based vaccine demand forecasting and inventory systems are operational in major hatcheries.
• 2030: Thermostable vaccines replace cold chain-reliant doses in 60+ countries
• 2031: mRNA vaccines commercialized for fast-mutating avian strains
For more insights, visit https://clearviewmarketinsights.com/
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
About Clearview Market Insights
Clearview Market Insights offers in-depth research on poultry health, disease prevention, and vaccine innovation. Our insights support hatcheries, integrators, and pharmaceutical leaders in developing safe, productive, and sustainable poultry systems.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Poultry Vaccines Market Expected to Exceed USD 8.1 Billion by 2031 as Biosecurity, Sustainability, and Recombinant Technologies Influence Global Immunization Programs here
News-ID: 4036369 • Views: …
More Releases from ClearView Market Insights
Sheep Genetics and Artificial Insemination Market to Surpass USD 2.06 Billion by …
[Canberra, May 21st, 2025] - The global sheep genetics and artificial insemination market, valued at USD 1.15 billion in 2024, is projected to grow at a CAGR of 8.5%, reaching USD 2.06 billion by 2031, according to Clearview Market Insights. This growth is driven by strategic breeding investments, AI training programs, and global collaborations in genetic improvement.
Request Sample @ https://clearviewmarketinsights.com/report-details/sheep-genetics-and-artificial-insemination-ai-market/
2024 Industry Milestones:
AI-Powered Sire Selection Tools Launched
• GenOvis incorporates feed efficiency and…
Sheep Health Monitoring & Wearables Market to Reach USD 1.48 Billion by 2031 Ami …
[Dunedin, New Zealand - May 21st, 2025] - According to Clearview Market Insights, the global Sheep Health Monitoring & Wearables Market, valued at USD 620 million in 2024, is projected to reach USD 1.48 billion by 2031, expanding at a CAGR of 12.9%. This growth is driven by the demand for early disease alerts, improved reproductive success, and scalable flock management.
Request Sample @ https://clearviewmarketinsights.com/report-details/sheep-health-monitoring-wearables-market/
2024 Industry Milestones:
Launch of Virtual Fencing…
Sheep Milk Products Market to Reach USD 10.1 Billion by 2031 Driven by Functiona …
[Toulouse, France - May 21st, 2025] - According to Clearview Market Insights, the global sheep milk products market, currently valued at USD 6.4 billion, is projected to grow at a CAGR of 6.7%, reaching USD 10.1 billion by 2031. This trend is bolstered by rising demand for nutrient-rich, gourmet, and lactose-friendly dairy solutions.
Request Sample @ https://clearviewmarketinsights.com/report-details/sheep-milk-products-market/
2024 Industry Milestones
Premium Sheep Cheese Sales Climb Worldwide
• Europe exports 18% more PDO sheep cheeses…
Sheep Parasite Control Market Expected to Exceed USD 3.44 Billion by 2031 as Res …
[Edinburgh, May 21st, 2025] - According to Clearview Market Insights, the global Sheep Parasite Control (Parasiticides) Market, valued at USD 2.1 billion in 2024, is projected to grow at a CAGR of 7.3%, reaching USD 3.44 billion by 2031. This surge is driven by threats of parasite resistance, climate-related pressures, and evolving best practices in flock health management.
Request Sample @ https://clearviewmarketinsights.com/report-details/sheep-parasite-control-parasiticides-market/
2024 Industry Milestones:
Launch of Combination Anthelmintics
• Zoetis expands Startect® dual-action…
More Releases for Vaccine
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%.
An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the…
